A Multicenter, Randomised, Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Vinflunine (Primary) ; Capecitabine
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Pierre Fabre
- 02 Feb 2017 Planned End Date changed from 1 Feb 2017 to 1 Apr 2017.
- 02 Feb 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Apr 2017.
- 02 Feb 2017 Status changed from recruiting to active, no longer recruiting.